Spex Technologies, Inc. v. Apricorn

Court of Appeals for the Federal Circuit·Decided October 14, 2022·No. 20-2210·Unpublished

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit

SPEX TECHNOLOGIES, INC.,

Plaintiff-Appellant

v.

APRICORN,

Defendant-Cross-Appellant

2020-2210, 2020-2253

Appeals from the United States District Court for the Central District of California in No. 2:16-cv-07349-JVS- AGR, Judge James V. Selna.

Decided: October 14, 2022

MARC A. FENSTER, Russ August & Kabat, Los Angeles, CA, argued for plaintiff-appellant. Also represented by PAUL ANTHONY KROEGER, BENJAMIN T. WANG.

OLIVER RICHARDS, Fish & Richardson P.C., San Diego, CA, argued for defendant-cross-appellant. Also represented by DAVID M. HOFFMAN, Austin, TX.

2 SPEX TECHNOLOGIES, INC. v. APRICORN

Before MOORE, Chief Judge, DYK and PROST, Circuit Judges.

PROST, Circuit Judge.

SPEX Technologies, Inc. (“SPEX”) sued Apricorn in the U.S. District Court for the Central District of California for infringing U.S. Patent No. 6,088,802 (“the ’802 patent”). During claim construction, the district court held that claims 6, 7, 23, and 25 of the ’802 patent were invalid as indefinite. SPEX thereafter tried claims 11 and 12 to a jury, and the jury found that Apricorn infringed those claims. After the verdict, Apricorn moved for judgment as a matter of law (“JMOL”) that it did not infringe. SPEX opposed; it also argued that if the district court were to grant the motion, it should at least give SPEX a new trial. But the district court granted JMOL of noninfringement and denied SPEX’s request for a new trial.

SPEX appeals the noninfringement JMOL, new-trial denial, and indefiniteness ruling. Apricorn conditionally cross-appeals. We affirm the noninfringement JMOL and new-trial denial, reverse the indefiniteness ruling, dismiss Apricorn’s conditional cross-appeal as moot, and remand for proceedings consistent with this opinion.

BACKGROUND

I

The ’802 patent concerns a “single integral peripheral device” that can perform (1) “security operations” on data stored in (or provided by or to) a “host computing device” and (2) a “defined interaction” with the host computing device , such as providing functionality like data storage, data communication, or user identification—what the patent calls “target functionality.” See ’802 patent col. 3 ll. 17–36, col. 4 l. 49–col. 5 l. 4. In plain terms, the ’802 patent’s peripheral device can perform security operations and another function—all in one device.

SPEX TECHNOLOGIES, INC. v. APRICORN 3

As relevant here, the ’802 patent’s peripheral device can perform security operations “in-line”—i.e., “between the communication of data to or from the host computing device and the performance of the target functionality.” Id. at col. 6 ll. 2–7; accord id. at Abstract. An “interface control device” ensures that data communicated between the host computing device and the target functionality undergoes security operations as appropriate.

Claim 11 contains a “means for mediating” element relating to this in-line concept (emphasis added):

11. A peripheral device, comprising: security means for enabling one or more security operations to be performed on data; target means for enabling a defined interaction with a host computing device; means for enabling communication between the security means and the target means; means for enabling communication with a host computing device; and means for mediating communication of data between the host computing device and the target means so that the communicated data must first pass through the security means.

II

A

During claim construction, the parties and district court agreed that the “means for mediating” element was a means-plus-function element subject to 35 U.S.C. § 112 ¶ 6, 1 which allows expressing a claim element as a “means

1 Congress has redesignated § 112 ¶¶ 2 and 6 as, respectively , § 112(b) and (f). See Leahy-Smith America 4 SPEX TECHNOLOGIES, INC. v. APRICORN

or step for performing a specified function” but limits the claim’s coverage to “the corresponding structure, material, or acts described in the specification and equivalents thereof.” Everyone also agreed that the function was “mediating communication of data between the host computing device and the target means so that the communicated data must first pass through the security means.” See SPEX Techs., Inc. v. Kingston Tech. Corp., No. SACV 16- 01790, 2017 WL 5495149, at *13 (C.D. Cal. Oct. 18, 2017) (“Claim Construction Order”).

The parties disagreed, however, as to whether the ’802 patent disclosed sufficient corresponding structure for performing that function. Apricorn argued that the patent failed to do so, rendering claim 11 (and its dependent claim 12) invalid as indefinite under § 112 ¶ 2. SPEX maintained that the interface control device 910 as shown in Figure 9B of the ’802 patent (“ICD 910”) supplied sufficient corresponding structure. Figure 9B is reproduced below:

Invents Act (“AIA”), Pub. L. No. 112-29, sec. 4(c), 125 Stat. 284, 296 (2011). The pre-AIA designations apply to the ’802 patent, so this opinion refers to those.

SPEX TECHNOLOGIES, INC. v. APRICORN 5

The district court agreed with SPEX that ICD 910 was a corresponding structure with disclosure sufficient to survive Apricorn’s indefiniteness challenge. In making this determination, the court relied heavily on a passage of the specification concerning the “configuration registers” of ICD 910. That passage states:

[ICD] 910 includes sets of configuration registers 911. The data stored in the configuration registers 911 establish operating characteristics of the [ICD]: in particular, the content of the configuration registers enables the [ICD] to present to the host computing device a desired identification of the peripheral device[] and determines whether data passing through the peripheral device must be subjected to security operations. A set of configuration registers is maintained for the host computing device I/O interface, the cryptographic processing device interface, and the target functionality interface.

’802 patent col. 17 ll. 25–36 (emphasis added). Aside from Figure 9B, the district court cited this passage—and only this passage—in rejecting Apricorn’s argument that ICD 910 had insufficient structural disclosure. Claim Construction Order, 2017 WL 5495149, at *15 (“Given the specific details provided in this disclosure, [Apricorn has] not proven by clear and convincing evidence that the structure of [ICD 910] is inadequately disclosed by the patent specification .”).

The district court accordingly construed the “means for mediating” element as a means-plus-function element subject to § 112 ¶ 6—the function being “mediating communication of data between the host computing device and the target means so that the communicated data must first 6 SPEX TECHNOLOGIES, INC. v. APRICORN

pass through the security means,” and the corresponding structure being ICD 910. Id. 2

B

SPEX tried claims 11 and 12 to a jury. As to the “means for mediating” element specifically, the district court instructed the jury consistent with its claim construction, setting forth both the function and the corresponding structure —i.e., ICD 910. J.A. 11276. As to infringement of means-plus-function elements generally, the court instructed the jury:

Free access — add to your briefcase to read the full text and ask questions with AI

Spex Technologies, Inc. v. Apricorn, (Fed. Cir. 2022).

Spex Technologies, Inc. v. Apricorn (Spex Technologies, Inc. v. Apricorn) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related